4.6 Article

A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients With Ulcerative Colitis, Using the Pictorial Representation of Illness and Self-measure Tool

Journal

JOURNAL OF CROHNS & COLITIS
Volume 15, Issue 2, Pages 228-237

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ecco-jcc/jjaa159

Keywords

PRISM; disease burden; quality of life

Funding

  1. AbbVie, Inc.

Ask authors/readers for more resources

The ICONIC study evaluated the burden of ulcerative colitis over a 2-year period using the PRISM tool, showing improvement in disease burden and suffering in patients with early UC. Physicians consistently underestimated disease severity and suffering compared to patients. The PRISM tool correlated with other measures of illness perception, supporting its use as an endpoint reflecting patient suffering.
Background: The understanding the Impact of ulcerative COlitis aNd Its assoCiated disease burden on patients study [ICONIC] was a 2-year, global, prospective, observational study evaluating the cumulative burden of ulcerative colitis [UC] using the Pictorial Representation of Illness and SelfMeasure [PRISM] tool that is validated to measure suffering, but has not previously been used in UC. Methods: ICONIC enrolled unselected outpatient clinic attenders with recent-onset UC. Patient-and physician-reported outcomes including PRISM, the Short Inflammatory Bowel Disease Questionnaire [SIBDQ], the Patient Health Questionnaire [PHQ-9], and the Simple Clinical Colitis Activity Indexes [patient: P-SCCAI; physician: SCCAI] were collected at baseline and follow-up visits every 6 months. Correlations between these measures were assessed using Spearman's rank correlation coefficient. Results: Overall, 1804 evaluable patients had Z1 follow-up visit. Over 24 months, mean [SD] disease severity measured by P-SCCAI/SCCAI reduced significantly from 4.2 [3.03.0 [3.0] to 2. [2.7]/1.3 [2.1] [p <0.0001]. Patient-/physician-assessed suffering, quantified by PRISM, reduced significantly over 24 months [p <0.0001]. P-SCCAI/SCCAI and patient-/physician-assessed PRISM showed strong pairwise correlations [rho A.60, p <0.0001], although physicians consistently underestimated these disease severity and suffering measures compared with patients. Patient-assessed PRISM moderately correlated with other outcome measures, including SIBDQ, PHQ-9, P-SCCAI, and SCCAI (rho = <=-0.38 [negative correlations] or >= 0.50 [positive correlations], p <0.0001). Conclusions: Over 2 years, disease burden and suffering, quantified by PRISM, improved in patients with relatively early UC. Physicians underestimated burden and suffering compared with patients. PRISM correlated with other measures of illness perception in patients with UC, supporting its use as an endpoint reflecting patient suffering.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available